Status:
COMPLETED
Exploring the Biological Basis of Chronic Fatigue Syndrome
Lead Sponsor:
DxTerity Diagnostics
Conditions:
Chronic Fatigue Syndrome
Eligibility:
All Genders
18-100 years
Brief Summary
To collect blood and urine samples from patients with Chronic Fatigue Syndrome (CFS), myalgic encephalomyelitis (ME), and SEID (Systemic Exertion Intolerance Syndrome) and controls for genomic, viral ...
Detailed Description
To analyze gene expression (genomic) and viral analysis data from patients diagnosed with ME/CFS, the study will collect blood samples (finger stick) and information from up to 500 subjects for analys...
Eligibility Criteria
Inclusion
- (Cohort 1)
- Male and female patients age 18 or older at the time of consent
- Have a permanent address in the United States for the duration of the study
- Have an email address and access to the internet for the duration of the study
- Able to provide unassisted informed consent
- Medical Record Consent (optional)
- Diagnosed with Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) OR
- Report experiencing one or more of the following symptoms (record all that apply):
- Greatly lowered ability to perform normal daily activities due to profound fatigue that has lasted for at least 6 months
- Worsening of (fatigue) symptoms after physical or mental activity that would not have caused a problem before illness (post-exertional malaise).
- Sleep Problems. Feel overly tired or unrefreshed even after a full night of sleep
- Problems with thinking and memory (trouble thinking quickly, remembering things, paying attention to details, have "brain fog") OR
- Worsening of symptoms while standing or sitting upright -
Exclusion
- Pregnancy
- Inclusion Criteria: (Cohort 2)
- Male and female patients age 18 or older at the time of consent
- Have a permanent address in the United States for the duration of the study
- Have an email address and access to the internet for the duration of the study
- Able to provide unassisted informed consent
- Medical Record Consent (optional)
Key Trial Info
Start Date :
May 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT04859257
Start Date
May 26 2021
End Date
December 1 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DxTerity Diagnostics Inc.
Compton, California, United States, 90220